|
2011-03-03 |
2011-03-01 |
S
Sale
|
Brennan Jeffrey P
SVP - Bus. & Commercial Dev.
Officer
|
1,264
-100.0%
30.00
37,920
USD
|
1,264
-100.0%
|
30.00
|
37,920
USD
|
|
|
2011-03-03 |
2011-03-01 |
S
Sale
|
Hicks Karen A
VP Human Resources
Officer
|
1,243
-100.0%
30.00
37,290
USD
|
1,243
-100.0%
|
30.00
|
37,290
USD
|
|
|
2011-03-02 |
2011-03-01 |
S
Sale
|
Caldwell William S
SVP - Drug Discovery and Dev.
Officer
|
11,360
-59.5%
30.00
340,800
USD
|
11,360
-59.5%
|
30.00
|
340,800
USD
|
|
|
2011-03-02 |
2011-02-28 |
S
Sale
|
Caldwell William S
SVP - Drug Discovery and Dev.
Officer
|
15,481
-66.7%
28.00
433,468
USD
|
15,481
-66.7%
|
28.00
|
433,468
USD
|
|
|
2011-02-18 |
2011-02-16 |
PS
Planned sale
|
Caldwell William S
SVP - Drug Discovery and Dev.
Officer
|
16,655
-68.3%
26.52
441,656
USD
|
16,655
-68.3%
|
26.52
|
441,656
USD
|
|
|
2011-01-20 |
2011-01-19 |
S
Sale
|
Richard John P
Non-Executive Director
|
5,000
-48.4%
27.11
135,543
USD
|
5,000
-48.4%
|
27.11
|
135,543
USD
|
|
|
2011-01-20 |
2011-01-19 |
S
Sale
|
Bencherif Merouane
SVP, Preclinical Research
Officer
|
30,203
-100.0%
27.09
818,257
USD
|
30,203
-100.0%
|
27.09
|
818,257
USD
|
|
|
2011-01-20 |
2011-01-18 |
S
Sale
|
Richard John P
Non-Executive Director
|
2,500
-31.9%
27.38
68,440
USD
|
2,500
-31.9%
|
27.38
|
68,440
USD
|
|
|
2011-01-20 |
2011-01-18 |
S
Sale
|
Bencherif Merouane
SVP, Preclinical Research
Officer
|
22,800
-100.0%
27.17
619,476
USD
|
22,800
-100.0%
|
27.17
|
619,476
USD
|
|
|
2011-01-18 |
2011-01-14 |
S
Sale
|
Hicks Karen A
VP Human Resources
Officer
|
1,719
-100.0%
27.50
47,273
USD
|
1,719
-100.0%
|
27.50
|
47,273
USD
|
|
|
2011-01-18 |
2011-01-13 |
S
Sale
|
Hicks Karen A
VP Human Resources
Officer
|
3,369
-100.0%
27.24
91,760
USD
|
3,369
-100.0%
|
27.24
|
91,760
USD
|
|
|
2011-01-13 |
2011-01-12 |
S
Sale
|
Hicks Karen A
VP Human Resources
Officer
|
11,231
-100.0%
27.18
305,298
USD
|
11,231
-100.0%
|
27.18
|
305,298
USD
|
|
|
2011-01-13 |
2011-01-11 |
S
Sale
|
Hicks Karen A
VP Human Resources
Officer
|
13,825
-100.0%
27.02
373,571
USD
|
13,825
-100.0%
|
27.02
|
373,571
USD
|
|
|
2010-12-23 |
2010-12-22 |
S
Sale
|
Musso Alan A
SVP, CFO & Treasurer
Officer
|
4,881
-63.6%
26.47
129,200
USD
|
4,881
-63.6%
|
26.47
|
129,200
USD
|
|
|
2010-12-23 |
2010-12-21 |
S
Sale
|
Musso Alan A
SVP, CFO & Treasurer
Officer
|
15,535
-84.7%
26.61
413,386
USD
|
15,535
-84.7%
|
26.61
|
413,386
USD
|
|
|
2010-12-21 |
2010-12-20 |
S
Sale
|
Dunbar Geoffrey C
SVP, Clin. Dev. & Reg. Affairs
Officer
|
8,882
-88.5%
26.02
231,120
USD
|
8,882
-88.5%
|
26.02
|
231,120
USD
|
|
|
2010-12-21 |
2010-12-17 |
S
Sale
|
Dunbar Geoffrey C
SVP, Clin. Dev. & Reg. Affairs
Officer
|
2,100
-64.6%
26.08
54,765
USD
|
2,100
-64.6%
|
26.08
|
54,765
USD
|
|
|
2010-12-20 |
2010-12-16 |
S
Sale
|
Hodges Mauri K
VP Fin + Corp Sys & Controller
Officer
|
2,700
-70.0%
25.24
68,142
USD
|
2,700
-70.0%
|
25.24
|
68,142
USD
|
|
|
2010-12-20 |
2010-12-16 |
S
Sale
|
Dunbar Geoffrey C
SVP, Clin. Dev. & Reg. Affairs
Officer
|
200
-14.8%
25.15
5,030
USD
|
200
-14.8%
|
25.15
|
5,030
USD
|
|
|
2010-12-14 |
2010-12-13 |
S
Sale
|
Caldwell William S
SVP - Drug Discovery and Dev.
Officer
|
12,000
-60.8%
23.95
287,377
USD
|
12,000
-60.8%
|
23.95
|
287,377
USD
|
|
|
2010-12-14 |
2010-12-13 |
S
Sale
|
Brennan Jeffrey P
SVP - Bus. & Commercial Dev.
Officer
|
10,000
-100.0%
23.86
238,553
USD
|
10,000
-100.0%
|
23.86
|
238,553
USD
|
|
|
2010-12-14 |
2010-12-10 |
S
Sale
|
Bencherif Merouane
SVP, Preclinical Research
Officer
|
32,093
-100.0%
24.05
771,955
USD
|
32,093
-100.0%
|
24.05
|
771,955
USD
|
|
|
2010-12-10 |
2010-12-08 |
S
Sale
|
Dunbar Geoffrey C
SVP, Clin. Dev. & Reg. Affairs
Officer
|
11,250
-90.7%
22.68
255,150
USD
|
11,250
-90.7%
|
22.68
|
255,150
USD
|
|
|
2010-11-18 |
2010-11-17 |
S
Sale
|
SKALETSKY MARK B
Non-Executive Director
|
29,500
-72.2%
22.00
649,000
USD
|
29,500
-72.2%
|
22.00
|
649,000
USD
|
|
|
2010-11-18 |
2010-11-17 |
S
Sale
|
BLIXT CHARLES A
Non-Executive Director
|
5,500
-100.0%
21.76
119,666
USD
|
5,500
-100.0%
|
21.76
|
119,666
USD
|
|
|
2010-11-18 |
2010-11-16 |
S
Sale
|
SKALETSKY MARK B
Non-Executive Director
|
3,000
-20.9%
21.76
65,295
USD
|
3,000
-20.9%
|
21.76
|
65,295
USD
|
|
|
2010-11-18 |
2010-11-16 |
S
Sale
|
BLIXT CHARLES A
Non-Executive Director
|
9,500
-100.0%
21.80
207,067
USD
|
9,500
-100.0%
|
21.80
|
207,067
USD
|
|
|
2010-11-09 |
2010-11-05 |
S
Sale
|
Hodges Mauri K
VP Fin + Corp Sys & Controller
Officer
|
1,400
-54.7%
25.01
35,014
USD
|
1,400
-54.7%
|
25.01
|
35,014
USD
|
|
|
2010-11-09 |
2010-11-05 |
S
Sale
|
Dunbar Geoffrey C
SVP, Clin. Dev. & Reg. Affairs
Officer
|
700
-37.8%
25.02
17,512
USD
|
700
-37.8%
|
25.02
|
17,512
USD
|
|
|
2010-11-05 |
2010-11-04 |
S
Sale
|
Hodges Mauri K
VP Fin + Corp Sys & Controller
Officer
|
7,800
-87.1%
25.08
195,605
USD
|
7,800
-87.1%
|
25.08
|
195,605
USD
|
|
|
2010-11-05 |
2010-11-04 |
S
Sale
|
Dunbar Geoffrey C
SVP, Clin. Dev. & Reg. Affairs
Officer
|
7,784
-87.1%
25.07
195,139
USD
|
7,784
-87.1%
|
25.07
|
195,139
USD
|
|
|
2010-11-05 |
2010-11-03 |
S
Sale
|
Hodges Mauri K
VP Fin + Corp Sys & Controller
Officer
|
1,000
-46.3%
25.06
25,055
USD
|
1,000
-46.3%
|
25.06
|
25,055
USD
|
|
|
2010-11-05 |
2010-11-03 |
S
Sale
|
Dunbar Geoffrey C
SVP, Clin. Dev. & Reg. Affairs
Officer
|
986
-46.1%
25.05
24,699
USD
|
986
-46.1%
|
25.05
|
24,699
USD
|
|
|
2010-10-28 |
2010-10-28 |
S
Sale
|
Musso Alan A
SVP, CFO & Treasurer
Officer
|
1,500
-34.9%
24.60
36,900
USD
|
1,500
-34.9%
|
24.60
|
36,900
USD
|
|
|
2010-10-28 |
2010-10-26 |
S
Sale
|
Musso Alan A
SVP, CFO & Treasurer
Officer
|
2,000
-41.7%
24.65
49,295
USD
|
2,000
-41.7%
|
24.65
|
49,295
USD
|
|
|
2010-10-26 |
2010-10-25 |
S
Sale
|
Musso Alan A
SVP, CFO & Treasurer
Officer
|
8,500
-75.2%
24.69
209,892
USD
|
8,500
-75.2%
|
24.69
|
209,892
USD
|
|
|
2010-10-26 |
2010-10-22 |
S
Sale
|
Musso Alan A
SVP, CFO & Treasurer
Officer
|
600
-17.7%
24.60
14,760
USD
|
600
-17.7%
|
24.60
|
14,760
USD
|
|
|
2010-08-03 |
2010-08-02 |
S
Sale
|
DUNTON ALAN W
Non-Executive Director
|
6,000
-100.0%
22.30
133,791
USD
|
6,000
-100.0%
|
22.30
|
133,791
USD
|
|
|
2010-07-27 |
2010-07-26 |
S
Sale
|
DUNTON ALAN W
Non-Executive Director
|
2,864
-100.0%
21.12
60,476
USD
|
2,864
-100.0%
|
21.12
|
60,476
USD
|
|
|
2010-07-27 |
2010-07-23 |
S
Sale
|
DUNTON ALAN W
Non-Executive Director
|
2,336
-100.0%
21.00
49,063
USD
|
2,336
-100.0%
|
21.00
|
49,063
USD
|
|
|
2010-07-19 |
2010-07-15 |
S
Sale
|
DUNTON ALAN W
Non-Executive Director
|
6,800
-100.0%
20.72
140,911
USD
|
6,800
-100.0%
|
20.72
|
140,911
USD
|
|
|
2010-05-24 |
2010-05-21 |
S
Sale
|
BROWN JULIA R
Non-Executive Director
|
7,307
-100.0%
23.13
169,018
USD
|
7,307
-100.0%
|
23.13
|
169,018
USD
|
|
|
2010-05-24 |
2010-05-20 |
S
Sale
|
BROWN JULIA R
Non-Executive Director
|
5,193
-100.0%
22.97
119,278
USD
|
5,193
-100.0%
|
22.97
|
119,278
USD
|
|
|
2010-05-19 |
2010-05-18 |
S
Sale
|
Musso Alan A
SVP, CFO & Treasurer
Officer
|
3,424
-55.0%
24.70
84,572
USD
|
3,424
-55.0%
|
24.70
|
84,572
USD
|
|
|
2010-05-19 |
2010-05-17 |
S
Sale
|
Musso Alan A
SVP, CFO & Treasurer
Officer
|
382
-12.0%
24.60
9,397
USD
|
382
-12.0%
|
24.60
|
9,397
USD
|
|
|
2010-05-19 |
2010-05-17 |
S
Sale
|
Musso Alan A
SVP, CFO & Treasurer
Officer
|
8,400
-75.0%
24.21
203,348
USD
|
8,400
-75.0%
|
24.21
|
203,348
USD
|
|
|
2010-05-18 |
2010-05-14 |
S
Sale
|
Richard John P
Non-Executive Director
|
8,500
-61.4%
24.22
205,863
USD
|
8,500
-61.4%
|
24.22
|
205,863
USD
|
|
|
2010-05-17 |
2010-05-13 |
S
Sale
|
Dunbar Geoffrey C
SVP, Clin. Dev. & Reg. Affairs
Officer
|
1,494
-56.4%
25.00
37,350
USD
|
1,494
-56.4%
|
25.00
|
37,350
USD
|
|
|
2010-05-17 |
2010-05-13 |
S
Sale
|
Hicks Karen A
VP Human Resources
Officer
|
1,469
-100.0%
25.00
36,725
USD
|
1,469
-100.0%
|
25.00
|
36,725
USD
|
|
|
2010-05-17 |
2010-05-13 |
S
Sale
|
Hodges Mauri K
VP Finance & Controller
Officer
|
1,402
-54.7%
25.00
35,050
USD
|
1,402
-54.7%
|
25.00
|
35,050
USD
|
|
|
2010-05-14 |
2010-05-13 |
S
Sale
|
Hicks Karen A
VP Human Resources
Officer
|
4,226
-100.0%
24.10
101,851
USD
|
4,226
-100.0%
|
24.10
|
101,851
USD
|
|
|
2010-05-13 |
2010-05-12 |
S
Sale
|
BROWN JULIA R
Non-Executive Director
|
7,500
-100.0%
23.05
172,875
USD
|
7,500
-100.0%
|
23.05
|
172,875
USD
|
|
|
2010-05-04 |
2010-05-03 |
S
Sale
|
Caldwell William S
SVP - Drug Discovery and Dev.
Officer
|
17,000
-68.7%
24.29
412,848
USD
|
17,000
-68.7%
|
24.29
|
412,848
USD
|
|
|
2010-05-04 |
2010-04-30 |
S
Sale
|
Caldwell William S
SVP - Drug Discovery and Dev.
Officer
|
15,263
-66.4%
24.27
370,506
USD
|
15,263
-66.4%
|
24.27
|
370,506
USD
|
|
|
2010-04-30 |
2010-04-29 |
S
Sale
|
Caldwell William S
SVP - Drug Discovery and Dev.
Officer
|
35,100
-81.9%
24.18
848,764
USD
|
35,100
-81.9%
|
24.18
|
848,764
USD
|
|
|
2010-04-30 |
2010-04-28 |
S
Sale
|
Caldwell William S
SVP - Drug Discovery and Dev.
Officer
|
16,000
-67.4%
24.00
384,000
USD
|
16,000
-67.4%
|
24.00
|
384,000
USD
|
|
|
2010-04-30 |
2010-04-28 |
S
Sale
|
Dunbar Geoffrey C
SVP, Clin. Dev. & Reg. Affairs
Officer
|
14,700
-92.7%
24.00
352,800
USD
|
14,700
-92.7%
|
24.00
|
352,800
USD
|
|
|
2010-04-28 |
2010-04-27 |
S
Sale
|
Dunbar Geoffrey C
SVP, Clin. Dev. & Reg. Affairs
Officer
|
200
-14.8%
24.00
4,800
USD
|
200
-14.8%
|
24.00
|
4,800
USD
|
|
|
2010-04-28 |
2010-04-27 |
S
Sale
|
Caldwell William S
SVP - Drug Discovery and Dev.
Officer
|
315
-3.9%
24.00
7,560
USD
|
315
-3.9%
|
24.00
|
7,560
USD
|
|
|
2010-04-28 |
2010-04-26 |
S
Sale
|
Dunbar Geoffrey C
SVP, Clin. Dev. & Reg. Affairs
Officer
|
257
-18.2%
24.00
6,168
USD
|
257
-18.2%
|
24.00
|
6,168
USD
|
|
|
2010-04-28 |
2010-04-26 |
S
Sale
|
Caldwell William S
SVP - Drug Discovery and Dev.
Officer
|
600
-7.2%
24.00
14,400
USD
|
600
-7.2%
|
24.00
|
14,400
USD
|
|
|
2010-04-22 |
2010-04-20 |
S
Sale
|
Caldwell William S
SVP - Drug Discovery and Dev.
Officer
|
15,900
-67.3%
23.00
365,700
USD
|
15,900
-67.3%
|
23.00
|
365,700
USD
|
|
|
2010-04-20 |
2010-04-19 |
S
Sale
|
Caldwell William S
SVP - Drug Discovery and Dev.
Officer
|
100
-1.3%
23.00
2,300
USD
|
100
-1.3%
|
23.00
|
2,300
USD
|
|
|
2010-04-20 |
2010-04-16 |
S
Sale
|
Caldwell William S
SVP - Drug Discovery and Dev.
Officer
|
36,946
-82.7%
23.02
850,371
USD
|
36,946
-82.7%
|
23.02
|
850,371
USD
|
|
|
2010-04-02 |
2010-03-31 |
S
Sale
|
Zorn Peter A
SVP, Lg Affrs, GC and Secrtary
Officer
|
313
-100.0%
19.41
6,075
USD
|
313
-100.0%
|
19.41
|
6,075
USD
|
|
|
2010-02-18 |
2010-02-16 |
S
Sale
|
SNYDERMAN RALPH
Non-Executive Director
|
15,000
-100.0%
19.92
298,821
USD
|
15,000
-100.0%
|
19.92
|
298,821
USD
|
|
|
2010-01-20 |
2010-01-15 |
S
Sale
|
Bencherif Merouane
VP, Preclinical Research
Officer
|
73,108
-100.0%
20.51
1,499,452
USD
|
73,108
-100.0%
|
20.51
|
1,499,452
USD
|
|
|
2010-01-06 |
2010-01-04 |
S
Sale
|
Bencherif Merouane
VP, Preclinical Research
Officer
|
7,735
-100.0%
20.81
160,946
USD
|
7,735
-100.0%
|
20.81
|
160,946
USD
|
|
|
2010-01-05 |
2009-12-31 |
S
Sale
|
Zorn Peter A
VP, Lg Affrs, GC and Secrtary
Officer
|
4,092
-100.0%
21.02
86,016
USD
|
4,092
-100.0%
|
21.02
|
86,016
USD
|
|
|
2010-01-05 |
2009-12-31 |
S
Sale
|
Zorn Peter A
VP, Lg Affrs, GC and Secrtary
Officer
|
312
-100.0%
21.30
6,647
USD
|
312
-100.0%
|
21.30
|
6,647
USD
|
|
|
2009-12-18 |
2009-12-16 |
S
Sale
|
Bencherif Merouane
VP, Preclinical Research
Officer
|
15,532
-66.8%
21.93
340,663
USD
|
15,532
-66.8%
|
21.93
|
340,663
USD
|
|
|
2009-12-18 |
2009-12-16 |
S
Sale
|
Caldwell William S
VP - Drug Discovery and Dev.
Officer
|
23,201
-75.0%
21.93
508,868
USD
|
23,201
-75.0%
|
21.93
|
508,868
USD
|
|
|
2009-12-18 |
2009-12-16 |
S
Sale
|
deBethizy J Donald
President and CEO
Executive Director
|
209,004
-100.0%
21.98
4,593,344
USD
|
209,004
-100.0%
|
21.98
|
4,593,344
USD
|
|
|
2009-12-18 |
2009-12-16 |
S
Sale
|
deBethizy J Donald
President and CEO
Executive Director
|
630
-0.3%
22.99
14,483
USD
|
630
-0.3%
|
22.99
|
14,483
USD
|
|
|
2009-12-18 |
2009-12-16 |
S
Sale
|
deBethizy J Donald
President and CEO
Executive Director
|
28,296
-11.9%
22.00
622,611
USD
|
28,296
-11.9%
|
22.00
|
622,611
USD
|
|
